Loading...
•
Dec 31, 2019
Cross Country Healthcare Q4 2019 Earnings Report
Cross Country Healthcare's Q4 2019 financial results were announced, revealing a year-over-year revenue increase of 7% and sequential increase of 3%.
Key Takeaways
Cross Country Healthcare reported a revenue increase of 7% year-over-year and 3% sequentially. The company's net loss attributable to common shareholders was $1.1 million, and diluted EPS was a loss of $0.03 per share. Adjusted EBITDA was $8.3 million, and adjusted EPS was $0.07.
Consolidated revenue increased by 7% year-over-year and 3% sequentially, reaching $215.1 million.
Net loss attributable to common shareholders was $1.1 million, a significant improvement from the prior year's $19.7 million loss.
Adjusted EBITDA improved to $8.3 million, representing 3.9% of revenue.
Adjusted EPS was $0.07, compared to $0.00 in the prior year.
Cross Country Healthcare
Cross Country Healthcare
Cross Country Healthcare Revenue by Segment
Revenue by Segment
Nurse and Allied Staffing Revenue
CapyFin.comPhysician Staffing Revenue
CapyFin.com Forward Guidance
The company provided guidance for the first quarter of 2020, with revenue expected to be between $207 million and $212 million.
Positive Outlook
- Revenue is expected to be between $207 million and $212 million.
- Year-over-year revenue change is projected to be 6% - 9%.
- Adjusted EBITDA is expected to be between $4.5 million and $5.5 million.
- Year-over-year Adjusted EBITDA change is projected to be 25% - 52%.
- Adjusted EPS is expected to be between $(0.03) and $0.00.
Challenges Ahead
- Sequential revenue change is projected to be (4)% - (1)%.
- Gross Profit Margin is expected to be 23.0% - 23.5%.
- Gross Profit Margin change is projected to be (170) bps - (120) bps both year-over-year and sequentially.
- Sequential Adjusted EBITDA change is projected to be (46)% - (34)%.
- Adjusted EPS is expected to be between $(0.03) and $0.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income